InvestorsHub Logo
Followers 20
Posts 604
Boards Moderated 0
Alias Born 09/25/2003

Re: None

Tuesday, 08/03/2021 3:57:15 PM

Tuesday, August 03, 2021 3:57:15 PM

Post# of 403658
If Sanofi can take Translate for $38 bucks a share as a Covid slayer; does that raise the bar to be the same for a potential for Briliacidin? I would think comparatively that IPIX has an equal if not better pipeline as an acquisition target.

From the distribution of Fierce Biotech today.

GLTA

Go B!!!


BRILACIDIN *426* THE SAFE COVID KILLER
RBL TESTED AND APPROVED AGAINST COVID19

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News